149 related articles for article (PubMed ID: 9515828)
21. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[TBL] [Abstract][Full Text] [Related]
22. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
23. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
Jarvis B; Faulds D
Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
[TBL] [Abstract][Full Text] [Related]
24. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
[TBL] [Abstract][Full Text] [Related]
25. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A
Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087
[TBL] [Abstract][Full Text] [Related]
26. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P; Shah M; Muley A
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[TBL] [Abstract][Full Text] [Related]
27. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
28. No effect of fluticasone propionate on linear growth in preschool children with asthma.
Stefanovic IM; Verona E; Cicak B; Vrsalovic R
Pediatr Int; 2011 Oct; 53(5):672-676. PubMed ID: 21342354
[TBL] [Abstract][Full Text] [Related]
29. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time.
Faul JL; Leonard CT; Burke CM; Tormey VJ; Poulter LW
Thorax; 1998 Sep; 53(9):753-61. PubMed ID: 10319057
[TBL] [Abstract][Full Text] [Related]
30. Fluticasone propionate and bronchial hyperresponsiveness in childhood asthma.
Direkwattanachai C; Limkittikul K; Kraisarin C; Sasisakulporn C; Benjaponpitak S
Asian Pac J Allergy Immunol; 1999 Jun; 17(2):63-7. PubMed ID: 10466540
[TBL] [Abstract][Full Text] [Related]
31. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
32. Effects of inhaled corticosteroids on growth.
MacKenzie C
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 2):S451-5. PubMed ID: 9563371
[TBL] [Abstract][Full Text] [Related]
33. Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma.
Anhøj J; Bisgaard AM; Bisgaard H
Pediatrics; 2002 Mar; 109(3):E40. PubMed ID: 11875168
[TBL] [Abstract][Full Text] [Related]
34. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
Todd G; Dunlop K; McNaboe J; Ryan MF; Carson D; Shields MD
Lancet; 1996 Jul; 348(9019):27-9. PubMed ID: 8691927
[TBL] [Abstract][Full Text] [Related]
35. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
36. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
37. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.
Kannisto S; Korppi M; Remes K; Voutilainen R
J Clin Endocrinol Metab; 2000 Feb; 85(2):652-7. PubMed ID: 10690871
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
Falcoz C; Horton J; Mackie AE; Harding SM; Daley-Yates PT
Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
[TBL] [Abstract][Full Text] [Related]
39. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
[TBL] [Abstract][Full Text] [Related]
40. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM
Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
